News
Epidermolysis bullosa classification criteria refined and ready
LONDON – Epidermolysis bullosa classification criteria have been reworked and are a further step in understanding the rare genetic disease.
News
Psoriasis ointment helped with itch, healing in phase 2 EB study
LONDON – Low-dose calcipotriol ointment significantly improved wound healing and itch in people with epidermolysis bullosa in a pilot study.
News
Losartan showing promise in pediatric epidermolysis bullosa trial
LONDON – No safety concerns have been seen so far with the antihypertensive drug losartan in children with the skin blistering disease.
News
High cost of wound dressings for epidermolysis bullosa highlighted
LONDON – Dressing and bandage costs were highest for study participants with the generalized severe subtype, at about $112,450 per patient...
News
Novel approaches to treating NASH in diabetes
BARCELONA –
News
Tumor surroundings may hold key to TNBC treatment optimization
Investigators say their retrospective study results demonstrate that each TNBC subtype is associated with specific tumor microenvironment profiles...
News
Cardiometabolic risk burden is high in under-50s with type 2 diabetes
BARCELONA – Younger people with type 2 diabetes need a more focused treatment strategy, irrespective of cardiometabolic risk.
News
Ketoacidosis is on the rise in children with type 1 diabetes
BARCELONA – Data highlight an increase in prevalence at diagnosis, but certain factors may help identify those most at risk.
News
Signs of adult diabetes apparent in very young children
BARCELONA – Disturbed HDL cholesterol metabolism may be one of the earliest features of type 2 diabetes.
News
Body weight influences SGLT2-inhibitor effects in type 1 diabetes
BARCELONA – Patients with a high body mass index gain the most benefit from sodium-glucose cotransporter 2 inhibitors added to insulin.
News
GABA falls short for type 1 diabetes prevention in children
BARCELONA – There was no difference in pancreatic beta-cell function as measured by meal-stimulated C-peptide levels.
News
SUSTAIN 10: Weight loss, glycemic control better with semaglutide than liraglutide
BARCELONA – Once-weekly treatment with subcutaneous semaglutide yielded greater reductions in HbA1c and body weight than once-daily...
News
Liraglutide ‘option’ for treating pediatric type 2 diabetes
BARCELONA – ELLIPSE trial shows clinicians aren’t limited to metformin and insulin for children with diabetes.
News
COMISAIR: CGM ‘makes the difference’ in type 1 diabetes
BARCELONA –